Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron P Schultz

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Brain : a Journal of Neurology|March 10, 2018
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageingJasmeer P Chhatwal, Aaron P Schultz, Keith A Johnson, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Alzheimer'S Research & Therapy|July 3, 2024
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegenerationRory Boyle, Diana L Townsend, Hannah M Klinger, et al.
Brain Informatics|January 27, 2025
Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Rethinking the residual approach: Leveraging machine learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The prognostic value of blood-based p-tau217 levels on progression to clinical impairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
JAMA Neurology|July 30, 2014
Functional connectivity in autosomal dominant and late-onset Alzheimer diseaseJewell B Thomas, Matthew R Brier, Randall J Bateman, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Nature Medicine|November 6, 2019
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case reportJoseph F Arboleda-Velasquez, Francisco Lopera, Michael O'Hare, et al.
JAMA Neurology|October 16, 2023
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer DiseaseZahra Shirzadi, Stephanie A Schultz, Wai-Ying W Yau, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Brain : a Journal of Neurology|March 10, 2018
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageingJasmeer P Chhatwal, Aaron P Schultz, Keith A Johnson, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Alzheimer'S Research & Therapy|July 3, 2024
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegenerationRory Boyle, Diana L Townsend, Hannah M Klinger, et al.
Brain Informatics|January 27, 2025
Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Rethinking the residual approach: Leveraging machine learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The prognostic value of blood-based p-tau217 levels on progression to clinical impairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
JAMA Neurology|July 30, 2014
Functional connectivity in autosomal dominant and late-onset Alzheimer diseaseJewell B Thomas, Matthew R Brier, Randall J Bateman, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Nature Medicine|November 6, 2019
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case reportJoseph F Arboleda-Velasquez, Francisco Lopera, Michael O'Hare, et al.
JAMA Neurology|October 16, 2023
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer DiseaseZahra Shirzadi, Stephanie A Schultz, Wai-Ying W Yau, et al.
Pageof 14